Cargando…

Ascites-derived IL-6 and IL-10 synergistically expand CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in ovarian cancer patients

Myeloid-derived suppressor cells (MDSC) play a key immunosuppressive role in various types of cancer, including ovarian cancer (OC). In this study, we characterized CD14(+)HLA-DR(–/lo) MDSC with a typical monocytic phenotype (M-MDSC) in the peripheral blood (PB) and ascites from OC patients. Compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Liangliang, Deng, Zhaoyang, Peng, Yaojun, Han, Lu, Liu, Jing, Wang, Linxiong, Li, Bohua, Zhao, Jian, Jiao, Shunchang, Wei, Huafeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652747/ https://www.ncbi.nlm.nih.gov/pubmed/29100353 http://dx.doi.org/10.18632/oncotarget.20164

Ejemplares similares

IL-6-stimulated CD11b(+)CD14(+)HLA-DR(−) myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
por: Chen, Miao-Fen, et al.
Publicado: (2014)

Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
por: Verschoor, Chris P., et al.
Publicado: (2013)

Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
por: Zhang, Bin, et al.
Publicado: (2013)

IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
por: Tobin, Richard P., et al.
Publicado: (2019)

IL-12 Enhances Immune Response by Modulation of Myeloid Derived Suppressor Cells in Tumor Microenvironment
por: Choi, Ji-Na, et al.
Publicado: (2019)

IL-7 treatment augments and prolongs sepsis-induced expansion of IL-10-producing B lymphocytes and myeloid-derived suppressor cells
por: Kulkarni, Upasana, et al.
Publicado: (2018)

Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production
por: Tachibana, Masashi, et al.
Publicado: (2019)

Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
por: Hyun, Shin Young, et al.
Publicado: (2020)

Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas
por: Dawod, Bassel, et al.
Publicado: (2020)

Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory Monocytes
por: Achmus, Lennart, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System
por: Stevenson, Mary M., et al.
Publicado: (2022)

IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway
por: Sumida, Kentaro, et al.
Publicado: (2015)

Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice
por: Ma, Zhanchuan, et al.
Publicado: (2020)

Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets
por: Tomić, Sergej, et al.
Publicado: (2019)

CD14(+) CD15(−) HLA-DR(−) myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
por: Bernsmeier, Christine, et al.
Publicado: (2018)

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms
por: Grohová, Anna, et al.
Publicado: (2020)

Monocytic Myeloid-Derived Suppressor Cells Inhibit Myofibroblastic Differentiation in Mesenchymal Stem Cells Through IL-15 Secretion
por: Cheuk, Yin Celeste, et al.
Publicado: (2022)

Myeloid-derived suppressor cells promote the formation of abdominal aortic aneurysms through the IL-3-ICOSL-ICOS axis
por: Lu, Li, et al.
Publicado: (2023)

Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
por: Yang, Guoliang, et al.
Publicado: (2017)

IL-6 Promotes the Proliferation and Immunosuppressive Function of Myeloid-Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer
por: Zheng, Zhong, et al.
Publicado: (2021)

Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer
por: Wang, Jun, et al.
Publicado: (2017)

Stem cell factor produced by tumor cells expands myeloid-derived suppressor cells in mice
por: Lee, Wei-Chen, et al.
Publicado: (2020)

CD33(+) HLA-DR(–) Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14(+) Subset
por: Hassan, Mirhane, et al.
Publicado: (2018)

Intratumoral HLA-DR(−)/CD33(+)/CD11b(+) Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Hasnis, Erez, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG
por: Evans, J Henry, et al.
Publicado: (2011)

Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers
por: YAZAWA, TAKASHI, et al.
Publicado: (2013)

IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer
por: Chen, Xiaowei, et al.
Publicado: (2015)

Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer
por: Guan, Ying, et al.
Publicado: (2017)

Polarization of granulocytic myeloid‐derived suppressor cells by hepatitis C core protein is mediated via IL‐10/STAT3 signalling
por: Wang, Meng, et al.
Publicado: (2018)

Obesity Promotes Tumor Immune Evasion in Ovarian Cancer Through Increased Production of Myeloid-Derived Suppressor Cells via IL-6
por: Yang, Qiannan, et al.
Publicado: (2021)

T(h)17, T(h)22, and Myeloid-Derived Suppressor Cell Population Dynamics and Response to IL-6 in 4T1 Mammary Carcinoma
por: Rasé, Viva J., et al.
Publicado: (2022)

Increased CD14(+)HLA-DR(−/low) Myeloid-Derived Suppressor Cells Correlate With Disease Severity in Systemic Lupus Erythematosus Patients in an iNOS-Dependent Manner
por: Wang, Zhitao, et al.
Publicado: (2019)

Circulating CD14(+)HLA-DR(−/low) Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome
por: Sun, Shipeng, et al.
Publicado: (2020)

Granulocytic myeloid-derived suppressor cells expand in cord blood and human pregnancy and modulate T cell responses
por: Köstlin, Natascha, et al.
Publicado: (2014)

P1255: TUMOR-ASSOCIATED MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS IS A POTENTIAL PROGNOSTIC BIOMARKER, PROMOTING MULTI-DRUG RESISTANCE IN NHL PATIENTS BY MODULATING IL-6/IL-10/IL-1Β AXIS
por: Dhar, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6i5uupnh9rqqfas48qv5jsf13j